Alkermes ALKS
NASDAQ ALKS
$43.39 -3.32 (-7.11%)
At close: Sep 18, 2026 · 4:00 PM EDT

Alkermes (ALKS) Revenue (2010 - 2026)

Alkermes' (ALKS) quarterly Revenue came in at $496.0 million in Q2 2026, up 26.97% year-over-year from $390.7 million in Q2 2025, and up 26.24% quarter-over-quarter from $392.9 million in Q1 2026.

Analysis

Alkermes (ALKS) Revenue (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Revenue for 17 consecutive years, with $496.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Revenue rose 26.97% year-over-year to $496.0 million in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 10.79% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 5.25% from the prior year.
  • Revenue was $496.0 million for Q2 2026 at Alkermes, up from $392.9 million in the prior quarter.
  • Over five years, Revenue peaked at $617.4 million in Q2 2023 and troughed at $252.4 million in Q3 2022.
  • A 5-year average of $372.1 million and a median of $379.5 million in 2023 frame the typical range for Revenue.
  • Across the five-year window, Revenue jumped 123.52% in 2023 and plunged 35.35% in 2024, its largest moves.
  • Over 5 years, Revenue stood at $304.7 million in 2022, then grew by 23.89% to $377.5 million in 2023, then advanced by 13.91% to $430.0 million in 2024, then dropped by 10.57% to $384.5 million in 2025, then advanced by 28.99% to $496.0 million in 2026.
  • The last three Revenue figures came in at $496.0 million (Q2 2026), $392.9 million (Q1 2026), and $384.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 25.31 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 16.99 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 14.41 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 15.03 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 12.97 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 13.48 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 1.71 Bn
10 Alkermes 7.27 Bn 6.61 Bn 397.90 Mn 496.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 496.01 Mn
Mar 31, 2026 392.91 Mn
Dec 31, 2025 384.55 Mn
Sep 30, 2025 394.19 Mn
Jun 30, 2025 390.66 Mn
Mar 31, 2025 306.51 Mn
Dec 31, 2024 429.99 Mn
Sep 30, 2024 378.14 Mn
Jun 30, 2024 399.13 Mn
Mar 31, 2024 350.37 Mn
Dec 31, 2023 377.48 Mn
Sep 30, 2023 380.94 Mn
Jun 30, 2023 617.40 Mn
Mar 31, 2023 287.60 Mn
Dec 31, 2022 304.67 Mn
Sep 30, 2022 252.36 Mn
Jun 30, 2022 276.22 Mn
Mar 31, 2022 278.55 Mn
Dec 31, 2021 324.46 Mn
Sep 30, 2021 294.14 Mn